No Data
Hsiang Sheng Healthcare: Report for the third quarter of 2024
Xiang Sheng Medical Report for the Third Quarter of 2024
Chison Medical Technologies (688358.SH): Plans to launch a restricted stock incentive plan for 2024.
Chison Medical Technologies (688358.SH) announced the restricted stock incentive plan for 2024, intending to grant 593,000 restricted stocks to incentive recipients, accounting for approximately 0.53% of the total share capital of 112,124,537 shares at the time of the announcement of this incentive plan. Among them, 475,500 shares are initially granted, representing around 0.42% of the total share capital of 112,124,537 shares at the time of the announcement of this incentive plan; the initial grant portion accounts for 80.19% of the total equity granted in this round; 117,500 shares are reserved, approximately
Kosei Medical 2024 Semi-Annual Report
Summary of the 2024 Semi-Annual Report of Xiang Sheng Medical
Chison Medical Technologies (688358.SH): net income of 81.3436 million yuan in the first half of the year, a year-on-year decrease of 27.35%.
Chison Medical Technologies (688358.SH) released the semi-annual report for 2024 on August 28. During the reporting period, the company achieved revenue of 24.8 billion yuan, a decrease of 16.47% year-on-year; the net income attributable to the shareholders of the listed company was 81.3436 million yuan, a decrease of 27.35% year-on-year; the net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 74.3068 million yuan, a decrease of 32.68% year-on-year; and the basic earnings per share was 0.73 yuan.
It's Down 26% But Chison Medical Technologies Co., Ltd. (SHSE:688358) Could Be Riskier Than It LooksNo Data
No Data
